Oncomine India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 4 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 25.00%
- Ebitda
- Net Worth -23.17%
- Total Assets %
About Oncomine India
Oncomine India Private Limited (OIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 28 January 2020 (Five years 4 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Sanghai and Anumeha Soni serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73200MH2020FTC336744
-
Company No.
336744
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
28 Jan 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Oncomine India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Sanghai
|
Director | 03-Jan-2024 | Current |
|
Anumeha Soni
|
Director | 13-Aug-2022 | Current |
Financial Performance of Oncomine India.
Oncomine India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 25% increase in profit. The company's net worth observed a substantial decline by a decrease of 23.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oncomine India?
Unlock access to Oncomine India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Thermo Fisher Scientific India Private LimitedManish Sanghai and Anumeha Soni are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oncomine India?
Unlock and access historical data on people associated with Oncomine India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oncomine India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncomine India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
